🇲🇽 Carvykti in Mexico

Carvykti (ciltacabtagene autoleucel) regulatory status in Mexico.

Marketing authorisation

COFEPRIS

  • Status: likely_approved

Carvykti in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Mexico

Frequently asked questions

Is Carvykti approved in Mexico?

Yes. COFEPRIS has authorised it.

Who is the marketing authorisation holder for Carvykti in Mexico?

Johnson & Johnson is the originator. The local marketing authorisation holder may differ — check the official source linked above.